Ticker League

EBITDA Margin for Gilead Sciences (GILD)

As of · Reported

Metric

TTM

44.8%

YoY change

+30.70pp

Trough year (1995)

-1066.7%

Peak year (2015)

71.8%

EBITDA Margin history chart for Gilead Sciences (GILD) from 1990 to 2025

Latest: 46.1%

EBITDA Margin change chart for Gilead Sciences (GILD) from 1990 to 2025

Latest: +30.70pp

EBITDA Margin history table for Gilead Sciences (GILD) from 1990 to 2025

  • 202546.1%+30.70pp
  • 202415.4%-23.29pp
  • 202338.7%+6.26pp
  • 202232.4%-9.04pp
  • 202141.5%+24.75pp
  • 202016.7%-16.93pp
  • 201933.7%-12.90pp
  • 201846.6%-14.46pp
  • 201761.0%-2.21pp
  • 201663.2%-8.59pp
  • 201571.8%+6.27pp
  • 201465.6%+22.18pp
  • 201343.4%-0.43pp
  • 201243.8%-5.78pp
  • 201149.6%-4.35pp
  • 201053.9%-0.04pp
  • 200954.0%-0.25pp
  • 200854.2%+1.85pp
  • 200752.4%-3.22pp
  • 200655.6%-0.84pp
  • 200556.4%+7.23pp
  • 200449.2%+8.79pp
  • 200340.4%+19.97pp
  • 200220.4%+65.79pp
  • 2001-45.3%-24.73pp
  • 2000-20.6%+2.52pp
  • 1999-23.1%+19.95pp
  • 1998-43.1%-0.08pp
  • 1997-43.0%+51.60pp
  • 1996-94.6%+972.06pp
  • 1995-1066.7%-427.89pp
  • 1994-638.8%—
  • 1992-392.9%-203.57pp
  • 1991-189.3%+118.41pp
  • 1990-307.7%—

EBITDA Margin values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Gilead Sciences (GILD)

According to Gilead Sciences's latest reported financial statements, the company's latest reported EBITDA margin is 44.8%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Gilead Sciences (GILD) EBITDA margin totalled 46.12% – expanded 30.7 percentage points year-over-year.

The record annual EBITDA margin stands at 71.83%, reached in 2015; the historical low of -1066.67% was recorded in 1995.

Gilead Sciences EBITDA Margin by Year

Gilead Sciences EBITDA Margin 2025: 46.1%

Gilead Sciences posted EBITDA margin of 46.12% in 2025, expanded 30.7 percentage points from 2024.

Gilead Sciences EBITDA Margin 2024: 15.4%

In 2024, Gilead Sciences reported EBITDA margin of 15.42%, contracted 23.3 percentage points from 2023.

Gilead Sciences EBITDA Margin 2023: 38.7%

Gilead Sciences EBITDA margin in 2023 was 38.71%, expanded 6.3 percentage points from 2022.

Gilead Sciences EBITDA Margin 2022: 32.4%

2022's EBITDA margin for Gilead Sciences came in at 32.45%, contracted 9.0 percentage points from 2021.

Gilead Sciences EBITDA Margin 2021: 41.5%

Gilead Sciences EBITDA margin in 2021 was 41.49%.

See more financial history for Gilead Sciences (GILD).

Sector peers by EBITDA Margin

Healthcare peers of Gilead Sciences (GILD), ranked by their latest EBITDA margin

Frequently asked questions

Gilead Sciences (GILD) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation